anda Pharmaceuticals Doses First Patient in Trial for CMT Type 2S Treatment dlvr.it/TLJSgT
0
1
0
57
Novavax’s Combo and Flu Vaccines Show Strong Immune Response in Early Phase 3 Trial dlvr.it/TLJLd0
0
1
0
78
MaxCyte and Ori Biotech Team Up to Streamline Autologous Cell Therapy Manufacturing dlvr.it/TLJ91W
0
1
0
55
Maryland's Governor Moore Announces $6.95 Million in ‘Build Our Future’ Grant Awards to Support Innovation Infrastructure Development dlvr.it/TLJ1Mk
0
1
0
49
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement dlvr.it/TLGvRY
0
1
0
38
IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, and NVIDIA dlvr.it/TLFyBy
0
1
0
59
Previous BHCR Crab Trap Winner Luminoah Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort dlvr.it/TLFqZM
0
1
0
26
GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals dlvr.it/TLCc9W
0
1
0
30
REGENXBIO Shares Promising Early Results from Gene Therapy Trial for Duchenne Muscular Dystrophy dlvr.it/TLCTKn
0
1
0
34
USP announces new Advanced Technologies Laboratory in Maryland to accelerate and scale pharmaceutical manufacturing innovations dlvr.it/TLBkxt
0
1
1
31
Welldoc Works with Lilly to Launch a New Personalized Health & Medicine Platform for Those Prescribed Lilly’s Incretin Therapies dlvr.it/TLBY78
0
1
0
20
Maryland Stem Cell Research Fund Announces Call for Applications for the July 2025 Cycle dlvr.it/TLBPVv
0
1
0
20
IonQ Completes Acquisition of Lightsynq, Accelerating Quantum Computing and Networking Roadmap dlvr.it/TL9GFz
0
1
0
43
CoapTech Raises New Funding Round Led by Good Growth Capital dlvr.it/TL85rX
0
1
0
18
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine dlvr.it/TL7GhT
1
1
0
36
Bizjournals: Virginia Tech seeks industry partners for Institute for Advanced Computing dlvr.it/TL74nY
0
1
0
25
Virginia Business: GO Virginia grant boosts biotech in Roanoke, New River Valley dlvr.it/TL6xGp
0
1
1
39
Cartesian Therapeutics Announces First Participant Enrolled in Phase 3 Trial of Descartes-08 for Myasthenia Gravis dlvr.it/TL4HDr
0
1
0
30
Introducing the HJF-MDC Venture Fund: Fostering Medical Innovations for Military and Civilian Applications dlvr.it/TL3Z4d
0
1
0
27